2019
DOI: 10.1172/jci.insight.131310
|View full text |Cite
|
Sign up to set email alerts
|

Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 62 publications
0
3
0
Order By: Relevance
“…Excess adiposity in GH-deficient patients can be improved by exogenous GH administration ( 43 ), an effect primarily attributed to GH’s lipolytic action. Male mice with adipocyte-specific deletion of GHR ( 36 ), JAK2 ( 17 19 , 37 ) or STAT5 ( 16 ) have increased adiposity also attributed to decreased lipolytic rates, and impaired lipolysis in STAT5 AKO mice has been attributed to decreased ATGL and CGI-58 levels in subcutaneous fat ( 16 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Excess adiposity in GH-deficient patients can be improved by exogenous GH administration ( 43 ), an effect primarily attributed to GH’s lipolytic action. Male mice with adipocyte-specific deletion of GHR ( 36 ), JAK2 ( 17 19 , 37 ) or STAT5 ( 16 ) have increased adiposity also attributed to decreased lipolytic rates, and impaired lipolysis in STAT5 AKO mice has been attributed to decreased ATGL and CGI-58 levels in subcutaneous fat ( 16 ).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, STAT5 proteins regulate adipocyte development [reviewed in ( 14 )], fat mass ( 10 ), and lipid metabolism ( 13 ), through mechanisms that remain enigmatic. JAK2-STAT5 signaling in various tissues contributes to obesity and T2DM ( 15 ), and disruption of the adipocyte JAK2-STAT5 pathway ( 16 ) improves systemic metabolism and liver function ( 17 19 ).…”
Section: Introductionmentioning
confidence: 99%
“…However, the extent to which steatosis vs loss of other actions of GHR-signaling contributes to liver injury remains to be determined. It has been shown that the steatosis and associated liver injury and tumor formation are not evident with congenital loss of both liver and adipose JAK2, suggesting GH-mediated metabolic dysfunction of adipose tissue contributes to liver injury in this model (Corbit et al 2019). However, it is becoming evident that hepatic DNL is a major driver of steatosis in mice and humans (Lambert et al 2014, Smith et al 2020) and suppression of DNL improves NASH in a murine diet-induced NASH model (Gapp et al 2020).…”
Section: Discussionmentioning
confidence: 70%